Medical research

Reinvigorating the clinical drug pipeline for TB

A research team led by scientists from the Broad Institute has uncovered a novel group of chemical inhibitors that can kill the bacteria that causes tuberculosis (TB). Importantly, these chemical compounds take aim at a previously ...

Medications

Computer program narrows drug candidates for treating COVID-19

While vaccination and public education concerning the transmission of the coronavirus causing COVID-19 have been at the forefront of our response to the pandemic, there remains an urgent need for pharmaceutical interventions ...

Medical research

How to pick a winner in clinical drug trials

When a drug fails late on in clinical trials it's a major setback for launching new medicines. It can cost millions, even billions, of research and development funds. Now, an 'adaptive' approach to clinical trials and a genetic ...

Oncology & Cancer

First made-in-Singapore cancer drug enters clinical testing

A made-in-Singapore cancer drug has advanced into clinical trials, charting a milestone in Singapore's biomedical sciences initiative that will go towards improving the lives of cancer patients in Singapore, and worldwide. ...

page 9 from 20